BioSpace News Archive

BioMidwest

ArcScan’s Insight® 100 Ophthalmic Ultrasound Imaging System Approved in ChinaFirst-of-its-Kind Computer-Controlled Robotic Instrument Receives NMPA Certification

ArcScan, Inc. announced that ArcScan Insight® 100 has received National Medical Products Administration approval in China.

May 13, 2024
·
3 min read
Business

Oncocyte to Announce First Quarter 2024 Financial Results

Oncocyte Corporation announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close.

May 13, 2024
·
1 min read
Business

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2024 and provided corporate updates.

May 13, 2024
·
8 min read
Business

Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three months ended March 31, 2024, and provides updates on its antiviral product pipeline, upcoming milestones and business activities.

May 13, 2024
·
13 min read
Genetown

X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

X4 Pharmaceuticals today announced that management will be participating in the upcoming H.C. Wainwright 2nd Annual BioConnect Investor Conference, taking place on May 20th, 2024, at the Nasdaq Stock Exchange in New York City.

May 13, 2024
·
1 min read
Policy

Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceScience 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA Inspection

Science 37 Holdings, Inc. announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation.

May 13, 2024
·
2 min read
Pharm Country

IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024

IN8bio presented in an oral session details about its robust and reproducible proprietary clinical-scale gamma-delta T cell manufacturing platform across different donor populations, at the American Society of Gene & Cell Therapy 2024 Annual Meeting.

May 13, 2024
·
5 min read
Biotech Bay

Excision BioTherapeutics Announces Data from the Phase 1/2 Trial of EBT-101 in HIV And In Vivo Efficacy Data in Herpes Virus and Hepatitis B

Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure latent viral infectious diseases, summarized the novel presentation of multiple studies at this week’s American Society of Gene and Cell Therapy (ASGCT) meeting.

May 13, 2024
·
4 min read
Genetown

Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Approach to Developing Novel Inhaled Therapies for Lung Diseases at the 2024 American Thoracic Society International Conference

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, announced multiple presentations at the 2024 American Thoracic Society International Conference being held May 17-22, 2024 in San Diego, CA.

May 13, 2024
·
4 min read
Business

Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones

Annexon, Inc., a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, highlighted portfolio progress and reported first quarter 2024 financial results.

May 13, 2024
·
11 min read